Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period
- PMID: 32291278
- PMCID: PMC7164482
- DOI: 10.1126/science.abb5793
Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period
Abstract
It is urgent to understand the future of severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) transmission. We used estimates of seasonality, immunity, and cross-immunity for human coronavirus OC43 (HCoV-OC43) and HCoV-HKU1 using time-series data from the United States to inform a model of SARS-CoV-2 transmission. We projected that recurrent wintertime outbreaks of SARS-CoV-2 will probably occur after the initial, most severe pandemic wave. Absent other interventions, a key metric for the success of social distancing is whether critical care capacities are exceeded. To avoid this, prolonged or intermittent social distancing may be necessary into 2022. Additional interventions, including expanded critical care capacity and an effective therapeutic, would improve the success of intermittent distancing and hasten the acquisition of herd immunity. Longitudinal serological studies are urgently needed to determine the extent and duration of immunity to SARS-CoV-2. Even in the event of apparent elimination, SARS-CoV-2 surveillance should be maintained because a resurgence in contagion could be possible as late as 2024.
Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.
Figures






Comment in
-
[Landspitali - National University Hospital during an epidemic].Laeknabladid. 2020 May;106(5):231. doi: 10.17992/lbl.2020.05.577. Laeknabladid. 2020. PMID: 32367808 Icelandic. No abstract available.
-
Web-based dermatology residency interviews in the time of coronavirus disease 2019 (COVID-19).J Am Acad Dermatol. 2020 Aug;83(2):707-708. doi: 10.1016/j.jaad.2020.05.025. Epub 2020 May 12. J Am Acad Dermatol. 2020. PMID: 32413445 Free PMC article. No abstract available.
-
Use of personal protective equipment while admixing antineoplastic drugs during the COVID-19 pandemic era: Questionnaire survey in Niigata, Japan.J Oncol Pharm Pract. 2020 Sep;26(6):1553-1554. doi: 10.1177/1078155220932342. Epub 2020 May 29. J Oncol Pharm Pract. 2020. PMID: 32469683 No abstract available.
-
Global Seasonality of Human Seasonal Coronaviruses: A Clue for Postpandemic Circulating Season of Severe Acute Respiratory Syndrome Coronavirus 2?J Infect Dis. 2020 Sep 1;222(7):1090-1097. doi: 10.1093/infdis/jiaa436. J Infect Dis. 2020. PMID: 32691843 Free PMC article.
-
Repurposing FDA-approved drugs for SARS-CoV-2 through an ELISA-based screening for the inhibition of RBD/ACE2 interaction.Protein Cell. 2021 Jul;12(7):586-591. doi: 10.1007/s13238-020-00803-w. Epub 2020 Nov 18. Protein Cell. 2021. PMID: 33210243 Free PMC article. No abstract available.
References
-
- World Health Organization, Coronavirus Disease 2019 (COVID-19) Situation Report – 66 (WHO, 2020); https://www.who.int/docs/default-source/coronaviruse/situation-reports/2....
-
- R. Li, C. Rivers, Q. Tan, M. B. Murray, E. Toner, M. Lipsitch, The demand for inpatient and ICU beds for COVID-19 in the US: lessons from Chinese cities. medRxiv 2020.03.09.20033241 [Preprint]. 16 March 2020; .10.1101/2020.03.09.20033241 - DOI
-
- “‘Not a wave, a tsunami.’ Italy hospitals at virus limit,” AP NEWS, 13 March 2020; https://apnews.com/a4497f31bf5dbc1ff263e4263fc9f69e.
-
- “COVID-19 infections rise in New York with peak weeks away.” AP NEWS, 25 March 2020; https://apnews.com/7c7563cb82626a4042797c6aa6da260a.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous